Predictive Oncology (NASDAQ: POAI), a leader in artificial intelligence (“AI”)-driven drug discovery and biologics, has completed a multiyear study through a partnership with UPMC Magee-Womens Hospital. The study was focused on evaluating the use of AI in building multiomic machine learning (“ML”) models and then testing the models to determine if they could learn associations between … Continue reading InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI), UPMC Magee-Womens Hospital Complete Ovarian Cancer Study